US Executive Officer Management Changes SEC — September 30, 2026

30-09-2026

General Mills announced that Dana McNabb, currently COO, will succeed Jeff Harmening as CEO effective January 1, 2027, with Harmening becoming Executive Chair. The company highlighted Harmening's tenure, during which it returned over $17 billion to shareholders and revamped a third of its portfolio, but McNabb emphasized that returning the company to profitable growth is the priority, implying recent performance challenges. Fiscal 2026 net sales were $18 billion, with an additional $1 billion from non-consolidated JVs.

• · McNabb has been with General Mills for 27 years, starting in Canada in 1999.
• · McNabb currently leads all four operating segments: North America Retail, North America Pet, North America Foodservice, and International.
• · McNabb previously served as Group President of North America Retail (2024) and added North America Pet in 2025.
• · Harmening has served as CEO for nearly a decade.
• · The board unanimously elected McNabb following a multi-year succession planning process.
• · McNabb holds a bachelor's degree from the University of Ottawa and an MBA from London Business School.

30-09-2026

Johnson Controls International plc disclosed that Julie Brandt, Vice President and President of Global Commercial and Field Operations, will depart as part of a planned transition tied to changes in the company's operating model. She will move to an advisory role from October 1, 2026, through December 31, 2026, and will receive severance benefits under the company's Severance and Change in Control Policy for Officers. The change is effective September 25, 2026, with the 8-K filed September 30, 2026.

• · Julie Brandt's departure is part of a planned transition related to changes in the company's operating model.
• · Advisory role begins October 1, 2026, and is expected to continue through December 31, 2026.
• · Severance benefits are governed by the Severance and Change in Control Policy for Officers (Exhibit 10.6 to the FY2025 Form 10-K).

30-09-2026

The Hartford announced a CEO succession plan: President A. Morris 'Mo' Tooker will become CEO effective March 1, 2027, succeeding Christopher Swift, who will transition to executive chair. Swift's tenure as CEO spanned nearly 13 years, during which net income ROE more than tripled and share price increased more than eightfold. The succession is designed to ensure strategic continuity, with Tooker joining the board on October 1, 2026.

• · Tooker joined The Hartford in 2015 as chief underwriting officer and has held increasingly senior roles over 11 years.
• · Swift will step down from executive chair role in the second half of 2027.
• · Tooker will join the board effective October 1, 2026.

30-09-2026

On September 29, 2026, Alicia Knapp, President Nuclear Development of American Electric Power (AEP), involuntarily left the company. Her separation triggers potential severance benefits under AEP's Executive Severance Plan, contingent on her signing a release and noncompetition agreement. The departure is a routine officer change with no financial impact disclosed.

• · Ms. Knapp's departure is involuntary, and she may receive one times her current salary and target annual incentive compensation, plus prorated vesting of performance shares and restricted stock units, if she signs the severance agreement.
• · The severance agreement includes a one-year noncompete clause and reaffirmation of non-solicitation, confidentiality, non-disparagement, and cooperation covenants.

30-09-2026

Moderna announced the addition of a Chief Operating Officer role as the company expands into oncology and infectious diseases. Juan Andres will return as COO effective October 5, 2026, while Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer, will retire after four years. The move supports the potential launch of intismeran autogene (jointly developed with Merck) following positive Phase 3 results and the recent FDA approval of Moderna's seasonal flu vaccine and EU authorization of its flu-COVID combination vaccine.

• · Juan Andres previously spent nearly six years at Moderna (2017-2023), serving as Chief Technical Operations and Quality Officer from 2018 through 2022, and later as President, Strategic Partnerships and Enterprise Expansion before retiring in 2023.
• · Jerh Collins joined Moderna in October 2022 and became Chief Technical Operations and Quality Officer in January 2023; he previously spent nearly 30 years at Novartis.
• · During his tenure, Collins helped transition Moderna's manufacturing footprint for an endemic vaccine market, advanced manufacturing capabilities in the UK, Canada and Australia, and established the manufacturing model to support intismeran autogene.
• · The new COO role is intended to support increasing scale and diversification as Moderna prepares for potential launch and scale-up of intismeran autogene and advances a broader oncology portfolio.

30-09-2026

Mattel announced that Roger Lynch, current Board member and Independent Lead Director, will succeed Ynon Kreiz as Chairman (effective October 2, 2026) and CEO (on or before November 2, 2026). Kreiz is stepping down to take a senior leadership role at another public company, and Diana Ferguson was appointed as the new Independent Lead Director. The company highlighted its strong position under Kreiz, including #1 global rankings in Dolls, Vehicles, and Infant/Toddler/Preschool, but also reiterated forward-looking risk factors including tariffs, inflation, and potential material weaknesses in internal controls.

• · Hot Wheels is on track for its ninth consecutive growth year.
• · Mattel achieved #1 global ranking in Dolls, Vehicles, and Infant, Toddler & Preschool categories.
• · Barbie was the #1 global box office film of 2023 and Warner Bros. Pictures' highest-grossing movie of all time.
• · Mattel has returned to investment-grade credit rating and resumed share repurchases.
• · The company has fully owned Mattel163 to accelerate digital gaming expansion.
• · Forward-looking risk factors include tariffs, inflation, currency fluctuations, and potential material weaknesses in internal controls.

30-09-2026

Luvulis Corporation appointed Guilherme Raphascki Menezes, age 24, as a director effective September 24, 2026, to serve until the next annual meeting. Mr. Raphascki Menezes, who has experience in corporate technology operations and financial analysis, has no compensatory arrangements or committee assignments. The appointment reflects a routine board change with no disclosed financial impact.

• · Mr. Raphascki Menezes has served as Operations Coordinator at Prometeia since 2025 and previously held positions at TeamSystem from 2024 to 2025.
• · He received his Bachelor's degree in Business Administration from FGV EAESP in 2024.
• · No arrangements, family relationships, or transactions requiring disclosure under Item 404(a) exist.
• · The Company has not entered into any compensatory arrangements with Mr. Raphascki Menezes.

30-09-2026

HealthEquity, Inc. (NASDAQ: HQY) announced the election of Noémie Heuland, CFO of Moody's Corporation, to its board of directors, effective September 24, 2026. The appointment expands the Board to 11 directors, nine of whom are independent, and Heuland will serve on the Audit and Risk and Cybersecurity and Technology Committees. This is a routine governance update with no financial impact disclosed.

• · Heuland has served as CFO of Moody's since April 2024.
• · Before Moody's, Heuland was CFO at Dayforce, Inc. from October 2020 to February 2024.
• · Heuland spent 12 years at SAP in finance leadership roles.
• · Heuland holds an M.S. in Finance and Accounting from Nantes Business School of Management (now Audencia) and is a Certified Public Accountant.
• · Heuland will serve on the Audit and Risk Committee and Cybersecurity and Technology Committee.

30-09-2026

Carlsmed appointed Richard Heppenstall as CFO, effective immediately, succeeding Leo Greenstein who is leaving to pursue other interests. The company reaffirmed its fiscal year 2026 revenue guidance of $74 to $78 million, representing 50% growth over 2025 at the midpoint. The new CFO brings nearly 30 years of experience in healthcare and technology, and the company highlighted upcoming product launches and a new CMS reimbursement effective October 1.

• · Richard Heppenstall previously served as EVP, CFO and Treasurer of ZimVie Inc. from September 2021 until its acquisition by ArchiMed SAS in October 2025.
• · Leo Greenstein had served as CFO since 2023 and was credited with stewardship through the IPO process.
• · CMS reimbursement for the aprevo® Lumbar spinal fusion procedure goes into effect on October 1, 2026.
• · Upcoming launches include the aprevo® Lumbar Bi-lateral procedure and corra™ cervical procedure.
• · Mr. Heppenstall holds an MBA from Santa Clara University and a BA in Economics from UC Irvine.

30-09-2026

Lee Enterprises appointed Gregory Hoffmann to its Board of Directors, effective immediately, with service until the 2028 annual meeting and membership on the Nominating and Corporate Governance Committee. The appointment adds financial and strategic expertise, though no financial metrics or operational changes were disclosed in the filing.

• · Gregory Hoffmann is Co-CEO of Hoffmann Family of Companies, leading strategic growth through acquisitions and development.
• · He began his career at Osprey Capital, LLC, where he played a key role in nearly doubling the firm's size.
• · He has led acquisitions totaling several billion dollars across Hoffmann portfolio companies.
• · He serves as Alternate Governor for the Pittsburgh Penguins of the NHL.
• · Lee Enterprises operates 193 owned and managed brands across 28 states, with markets including St. Louis, Buffalo, Omaha, Richmond, Lincoln, Madison, and Davenport.

30-09-2026

Albertsons Companies, Inc. (NYSE: ACI) announced the appointment of Bill Boltz, Chris Drumgoole, and Meg Ham to its Board of Directors, effective October 14, 2026, expanding the board from 11 to 14 members following the recent appointment of Meg Whitman as Executive Chair. The new directors bring expertise in retail merchandising, technology, AI, and grocery operations. No financial metrics or performance changes were disclosed in this filing.

• · Board expands from 11 to 14 members effective October 14, 2026
• · Bill Boltz has over 40 years of retail experience, including senior roles at Lowe's, The Home Depot, Sears, and Chevron North America
• · Chris Drumgoole previously served as President of Global Infrastructure Services at DXC Technology and CIO at General Electric
• · Meg Ham led Food Lion's turnaround with 50 consecutive quarters of comparable-store sales growth
• · Albertsons operates 2,240 retail stores across 35 states and the District of Columbia as of June 20, 2026
• · Company operates under 22 banners including Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, and ACME

30-09-2026

Regeneron Pharmaceuticals granted 2026 performance stock units (PSUs) to its CEO and CSO under a new long-term incentive program, with activity-based and revenue-based earnout opportunities tied to new product filings, FDA approvals, and new product annual revenues through 2035. The awards include absolute caps of 2,700,000 PSUs (CEO) and 2,900,000 PSUs (CSO), a relative TSR modifier of ±20%, and a 20% holdback on early deliveries. However, no additional equity awards are permitted until 2036, and unvested PSUs are forfeited on voluntary departure, with earnout caps limiting near-term payouts.

• · The 2026 PSUs include a 20% holdback on shares delivered before the end of the Performance Period.
• · No additional equity awards for CEO and CSO until 2036.
• · Earnout caps before 2034: no Revenue-Based PSUs in 2026-2031; cumulative cap on Activity-Based PSUs of 100,000 (CEO) and 300,000 (CSO) in 2026-2031.
• · Revenue-Based PSUs cannot be delivered before 2033.
• · The rTSR Modifier may not increase earned PSUs if Regeneron's absolute TSR is negative.
• · Upon termination without Cause or for Good Reason, unvested PSUs may be earned based on New Products in existence as of termination date.
• · The 2026 PSUs are subject to the Company's Clawback Policy and Recoupment Policy.

30-09-2026

Ultra Clean Holdings, Inc. (Nasdaq: UCTT) announced the appointment of Alexander Davern to its Board of Directors, effective September 28, 2026. Davern brings over 30 years of leadership experience in industrial and technology-intensive businesses, including nearly three decades at National Instruments where he served as CEO, COO, and CFO. The appointment is part of the company's UCT 3.0 strategy execution, with CEO James Xiao highlighting Davern's expertise in strengthening the Board's strategic insight for long-term growth.

• · Davern currently serves as Audit Chair of Cirrus Logic, Compensation Chair of Computer Modeling Group, and a director of Spectris.
• · His prior board roles include Chairman of ESI Group, Lead Independent Director of FARO Technologies, and director positions at Helen of Troy and SigmaTel.
• · He holds a Bachelor of Commerce degree and a diploma in professional accounting from University College Dublin.

30-09-2026

Atlantica Inc. reported the resignation of CFO Shelley Goff, effective September 30, 2026, simultaneously with the filing of the 8-K. The resignation was not due to any disagreement with the company. No replacement or succession plan was disclosed.

• · CFO resignation effective September 30, 2026
• · Resignation not related to any disagreement with the company
• · No successor or interim CFO announced

30-09-2026

On September 28, 2026, Halozyme Therapeutics, Inc. elected James Daly to its Board of Directors, with a term expiring at the 2029 annual meeting. Mr. Daly will receive standard non-employee director compensation, including cash retainers and equity awards, and has no related-party transactions or arrangements with the company.

• · Mr. Daly was not initially assigned to any Board committee.
• · Director compensation program details were described in the proxy statement for the 2026 Annual Meeting of Stockholders held on May 5, 2026.

30-09-2026

JLL announced that Mihir Shah, CEO of JLL Technologies and a member of the Global Executive Board, will depart effective April 1, 2027. He will receive severance of 54 weeks' base salary ($675,000), a pro-rated AIP bonus ($590,000), and an additional payment equal to one times his target annual incentive ($2,360,000), subject to a separation agreement. The departure is a scheduled executive transition with no negative performance indicators cited.

• · Separation effective April 1, 2027; Agreement signed September 28, 2026.
• · Mr. Shah's equity awards will vest pro-rated based on service; unvested portion forfeited.
• · Company will reimburse employer's share of COBRA premiums for up to 12 months.
• · Separation Agreement includes a 12-month non-solicitation covenant and confidentiality obligations.

30-09-2026

Exascale Labs Holdings Inc. (XLAB) announced the departure of Interim CFO Gildas Bonnier effective September 25, 2026, and the appointment of Jake Carney as permanent CFO on the same date. Mr. Carney, 38, brings 15 years of experience in banking, investment advisory, and fintech, and will receive a base salary of $6,000 per month. The changes were not due to any disagreement with the company.

• · Jake Carney previously served as CFO of ARC Group Securities Acquisition I, a Nasdaq-listed SPAC.
• · Mr. Carney's prior roles include Managing Director at ARC Group Limited (Sept 2022 – Apr 2025) and Investment Director at Beehive Fintech (Dec 2017 – Aug 2022).
• · He holds a BSc in Accounting and Finance from Dublin Institute of Technology and a Professional Diploma in Financial Advice from the Institute of Banking.
• · No family relationships or material transactions exist between Mr. Carney and the company's directors or officers.

30-09-2026

Virtuix Holdings Inc. held its 2026 Annual Meeting on September 24, 2026, where stockholders elected three Class I directors and ratified the appointment of the independent registered public accounting firm. Following the meeting, the Board approved a supplemental grant of 100,000 RSUs to CFO Thomas McGinnis, vesting over four years. The RSU grant is discretionary and subject to forfeiture upon termination, with no financial impact disclosed.

• · Votes for Proposal 2 (ratification of auditor): 85,819,980 for, 58,370 against, 193,878 abstentions, 0 broker non-votes
• · Votes for Proposal 1 (director election): 80,747 for, 3,120,728 against (per excerpt, likely incomplete)
• · Randolph C. Read has served as independent director since August 2025 and chairs the Audit Committee
• · Emerging Growth Company status elected not to use extended transition period

30-09-2026

TScan Therapeutics, Inc. entered into separation agreements with former CFO Jason A. Amello and former CMO Chrystal Louis, M.D., MPH, formalizing their departures as part of a strategic reorganization previously disclosed on September 2, 2026. Both executives will remain employed through the earlier of November 1, 2026 or when they commence other employment, with continued base salary and benefits. Each is eligible for a milestone-based retention award: $85,000 for Mr. Amello and $125,000 for Dr. Louis, under the November 2025 Retention Program.

• · Separation agreements were entered into on September 24, 2026 (Dr. Louis) and September 25, 2026 (Mr. Amello).
• · Employment terminates on the earlier of November 1, 2026 or the date the executive commences other employment, consulting, or paid board service.
• · Both executives remain contractually entitled to previously disclosed termination-related payments and benefits.
• · The milestone-based awards are contingent on achievement prior to the respective Separation Date.

30-09-2026

Cycurion, Inc. (NASDAQ: CYCU) resolved a John Doe defamation action in the U.S. District Court for the Eastern District of Virginia, after the anonymous defendant admitted his fraud and securities violation accusations were false and signed a retraction and apology. The settlement includes a permanent ban on the defendant trading Cycurion securities or making further disparaging statements, plus a cooperation obligation regarding short selling and naked short selling. Chairman and CEO L. Kevin Kelly emphasized the company's commitment to holding anonymous posters accountable, but noted that other previously disclosed legal matters remain pending.

• · The settlement includes a confession of judgment held in escrow, with additional remedies available if the defendant breaches the agreement.
• · The defendant is required to cooperate regarding short selling and naked short selling of Cycurion stock, and any coordination with other investors, short sellers, or market makers.
• · Cycurion will continue to identify anonymous posters and compel their identities through the courts.
• · Separate previously disclosed legal matters remain pending and will be addressed in later updates.
• · The company serves government, healthcare, and corporate clients, with subsidiaries including Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc.

30-09-2026

Levi Strauss & Co. (NYSE: LEVI) announced the appointment of John Vandemore as Executive Vice President and Chief Financial Officer, effective November 1, 2026. Vandemore brings over 25 years of finance leadership experience, most recently as CFO of Skechers U.S.A., where he helped nearly triple revenues to over $9 billion. The appointment follows the planned retirement of Harmit Singh, who will remain as CFGO until Vandemore joins and then serve as Special Advisor through November 30, 2026.

• · Vandemore previously served as CFO of Skechers for nine years, overseeing global finance, supply chain, digital, and IT functions.
• · Vandemore's prior roles include CFO of Walt Disney Imagineering and CFO of International Game Technology.
• · Vandemore holds an MBA from Northwestern University and a BBA from the University of Notre Dame.
• · Harmit Singh's retirement was announced in April 2026, with transition support through November 30, 2026.

30-09-2026

Kardigan, Inc. announced the appointment of Kristin Reinke to its Board of Directors as chair of the Audit Committee, effective September 29, 2026, replacing Doug Giordano who stepped down. Reinke brings AI-driven finance expertise from Google and financial governance experience as a CPA, which the company expects to support its integration of Prolaio's data platform and late-stage pipeline commercialization.

• · Reinke has been on Google's finance leadership team since 2005, helping the company grow from a startup to a multibillion-dollar enterprise.
• · She previously held leadership roles at Oracle and began her career at Arthur Andersen.
• · Reinke serves as an independent director and audit committee chair on the board of Everly Health.
• · She is a CPA and holds a bachelor's degree in accounting from Michigan State University.
• · Giordano was a founding member of the Board.

30-09-2026

City Holding Company (NASDAQ: CHCO) appointed Jessica Alsop to its Board of Directors, effective immediately, with her election to be recommended at the April 2027 annual meeting. Alsop brings extensive legal and corporate governance experience from her role as SVP and chief legal officer at WVU Health System. The company, a $6.8 billion bank holding company, operates 95 branches across four states.

• · Alsop's appointment is effective immediately; she will stand for election at the April 2027 annual meeting.
• · Board expects to recommend Alsop as a Class I director, with term expiring at the 2030 annual meeting.
• · Alsop has been WVU Health System's SVP and chief legal officer since 2019, joining in 2015.
• · Prior experience includes in-house counsel at Noble Energy and 12 years in private practice at Jackson Kelly.
• · Alsop currently serves as vice chair of The Education Alliance board and has held board roles with United Way, Children's Therapy Clinic, and University of Charleston.
• · City Holding Company is headquartered in Charleston, WV.

30-09-2026

Fortrea Holdings Inc. appointed Carrie Russell as Chief Accounting Officer, effective October 5, 2026. Ms. Russell had been serving as interim Chief Accounting Officer since August 7, 2026, and will continue in her role as Vice President of Accounting. Her compensation package includes an annual base salary of $340,000 and an annual incentive bonus target of 40% of base salary.

• · Ms. Russell's appointment is effective October 5, 2026.
• · She served as interim Chief Accounting Officer since August 7, 2026.
• · She will continue as Vice President of Accounting.
• · Compensation package includes eligibility for annual long-term incentive awards in the form of performance stock units and restricted stock units under the 2023 Omnibus Incentive Plan.
• · No arrangements or understandings with any other person regarding her appointment.
• · No family relations with any directors or executive officers of the company.

30-09-2026

Cars.com Inc. (NYSE: CARS) announced the appointment of Trent Ziegler as CFO-Designate, effective October 19, 2026, and he will formally succeed Sonia Jain as CFO on November 6, 2026. Jain will remain as Executive Advisor through March 31, 2027, to ensure an orderly transition. The company highlighted Ziegler's extensive financial leadership experience, while also acknowledging Jain's contributions to the company's post-spin-off evolution.

• · Trent Ziegler previously served as CFO at FairSquare, a fintech holding company.
• · Ziegler spent over a decade at LendingTree, including three years as CFO and seven years leading Investor Relations and Treasury.
• · Sonia Jain will serve as Executive Advisor through March 31, 2027.
• · Ziegler began his career at Ally Financial Inc.